Breakthrough Cystic Fibrosis Treatment on the Horizon
Elated. Nervous. Hopeful. That’s how thousands of cystic fibrosis patients felt upon hearing last week’s news: the Food and Drug Administration will soon review a new triple combination therapy that could drastically improve their quality of life.
ICER’s Message of Hopelessness
The Institute for Clinical and Economic Review is dashing patients’ hopes yet again.
Health Plan Barriers & Migraine Are a Losing Combination
Migraine disease exists on a spectrum, presenting patients with different frequencies of attacks, whose duration and effect vary from person to person.
More than a Punchline
Most people have a stereotypical perception of Tourette syndrome. Likely based on a movie or TV show, their vision is of an uncontrollable stream of insults and curse words. On the screen, these symptoms become the joke, the punchline. Yet cliché portrayals of Tourette syndrome are not only oversimplified, but also harmful.
Medicare Does About-Face on 6 Protected Classes
Cancer patients are breathing a sigh of relief. So are patients with movement disorders. And those with epilepsy, HIV and mental health conditions. In a final rule released earlier this month, the Centers for Medicare and Medicaid Services stepped back from a previous proposal to loosen Medicare protections for six classes of drugs that treat […]
What You Didn’t Know About Gout
Whoever coined the old adage that “ignorance is bliss” clearly wasn’t thinking of gout.
FDA Gives Final Word on Interchangeable Biosimilars
New guidance from the Food and Drug Administration explains what manufacturers must do to qualify their biosimilar medicine as interchangeable with its reference product.
Cardiovascular Summit Spotlights Stories of Access Barriers, Risk and Heart Health
Sandeep Jauhar’s grandfather was sitting down to lunch with family when he crumpled to the floor.
UK Study Reinforces Need for Personalized Treatment Plans
High cholesterol? For most patients, that means starting a statin regimen. But now research suggests that it may be time to embrace a more nuanced approach to lowering LDL levels.
Making Clinical Trials Participation Free for Patients
People who enroll in a clinical trial might be drawn to unexplored treatment options.
